Adagene

Adagene is a global, clinical-stage immunotherapy company that specializes in antibody-based cancer therapies. They are publicly traded on the NASDAQ stock exchange and are committed to transforming the discovery and development of novel antibody-based immunotherapies. Their focus is on creating therapeutic antibodies with unique functional epitopes and species cross-reactivity, enabling them to advance from lead identification through rigorous preclinical modeling to biomarker-guided mono- and combination immunotherapy development in clinical settings.

Adagene's core technology is built upon their understanding of the dynamic conformational diversity of proteins, which they leverage through their proprietary AI-Powered DPL platform. This platform allows them to explore the flexible binding sites of antibody sequences, resulting in a dynamic precision library of approximately one trillion antibody sequences. This extensive library maximizes the chances of finding suitable leads during the initial discovery phase. Adagene has developed a robust pipeline of innovative product candidates in various stages of development, ranging from research and discovery to preclinical and clinical development. Their clinical-stage pipeline consists of ADG106, ADG126, and ADG116, while they also have a robust preclinical pipeline in various stages of development.

Adagene offers a flexible work environment with some remote positions available. They currently have a job posting for a Head of Global Regulatory Affairs role that is remote. While not explicitly stated, the job posting for Director, Study Physician indicates a US location but does not explicitly state whether it is office-based or remote.

Adagene, a global, clinical-stage immunotherapy company, is dedicated to revolutionizing the discovery and design of therapeutic antibodies for cancer treatment. By leveraging their proprietary AI-powered platform and a deep understanding of protein dynamics, they create novel antibodies that overcome safety limitations and improve efficacy, offering hope to patients battling cancer. Their mission is to push the boundaries of antibody discovery and engineering, bringing innovative therapies to patients worldwide.

Adagene cultivates a culture of innovation and collaboration, driven by a shared passion to improve patient lives. As a global company with offices in China, the US, Singapore, and Australia, Adagene embraces diversity and inclusion. The company emphasizes a commitment to pushing the boundaries of antibody discovery and engineering, creating an environment where talented, self-motivated individuals can contribute their unique expertise and work together to achieve groundbreaking results.

Adagene is committed to fostering a diverse and inclusive workplace, prohibiting discrimination and harassment of any kind based on protected characteristics, including race, color, religion, sex, sexual orientation, gender identity, national origin, disability, pregnancy, veteran status, or other legally protected characteristics. The company actively seeks talented individuals from a range of backgrounds and experiences to contribute to its mission of advancing antibody therapeutics.